GENE REGULATION OF THE CYTOKINES IL-3 AND GM-CSF
细胞因子 IL-3 和 GM-CSF 的基因调控
基本信息
- 批准号:3242634
- 负责人:
- 金额:$ 19.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-08-01 至 1995-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein T lymphocyte cell growth regulation cell type chromatin clone cells colony stimulating factor complementary DNA cytokine fibroblasts gel electrophoresis gene expression genetic regulation genetic transcription granulocyte hematopoietic stem cells immunogenetics interleukin 3 methylation molecular cloning neurons nucleic acid sequence nucleoproteins oligonucleotides pancreatic ribonuclease transfection
项目摘要
The proliferation and maturation of hematopoietic stem and progenitor cells
is strongly affected by the availability and supply of hematopoietic growth
factors, particularly interleukin-3 (IL3) and granulocyte-macrophage colony
simulating factor (GM-CSF). As a result, regulation of IL-3 and GM-CSF gene
expression will weigh heavily in the process of hematopoietic
differentiation. To gain some insights into the molecular events underlying
their regulation, IL-3 and GM-CSF gene expression will be first be examined
in a model cell line, MLA 144 gibbon T leukemic cells. It will subsequently
be broadened to human T lymphocytes, macrophages and fibroblasts. Two broad
issues will be addressed. First, experiments are described to identify DNA
regions of IL-3 and GM-CSF genes responsible for transcriptional
activation, and to characterize and clone nuclear factors which interact
with such regions. Transient transfection and RNase protection assays will
be performed to identify the regulatory DNA regions which confer
transcriptional activation of the cytokine genes. These DNA sequences will
be used to identify nuclear factors in gel retardation assays, and various
criteria will be applied to characterize the nuclear protein-DNA complexes,
including DNA sequence specificity, DNA footprinting, and methylation
interference. Mutagenesis of the contact points between DNA and the bound
factors will be performed and its effect on DNA binding and transcriptional
activation of reporter genes in which the mutated motif replaces wild-type
sequences will be assessed. Nuclear factors which are confirmed to
participate in the regulation of expression of the two cytokines will be
cloned by screening cDNA expression libraries with oligonucleotides
consisting of tandem repeats of the bound DNA sequence, or by direct
expression in COS cells and gel retardation assay. Also, the nature and
role of jun and fos (or their related proteins) will be evaluated in the
activation of the IL-3 gene. Second, we will investigate in molecular terms
how expression of IL-3 and GM-CSF, in contrast to T cells, is uncoupled in
macrophage and fibroblast cells. Chromatin structure, promoter activities
and DNA nuclear proteins will be compared and characterized in the
different cell types using the same techniques listed earlier. Molecular
cloning of new nuclear factors, if identified, will also be carried out. In
addition to these topics, the possibility of IL-3 expression by human
neuronal cells will be investigated by conventional RNA analyses.
造血干、祖细胞的增殖和成熟
在很大程度上受到可获得和供应的造血生长的影响
因子,特别是白细胞介素3(IL3)和粒-巨噬细胞集落
模拟因子(GM-CSF)。因此,IL-3和GM-CSF基因的调控
表达将在造血过程中发挥重要作用
差异化。以获得对潜在的分子事件的一些见解
他们的调节,IL-3和GM-CSF的基因表达将首先被检测
在一个模型细胞系中,MLA 144长臂猿T白血病细胞。随后,它将
扩增至人T淋巴细胞、巨噬细胞和成纤维细胞。两个宽
问题将得到解决。首先,描述了识别dna的实验。
IL-3和GM-CSF基因转录调控区
激活,并鉴定和克隆相互作用的核因子
有这样的地区。瞬时转染和核糖核酸酶保护分析将
被用来识别与
细胞因子基因的转录激活。这些DNA序列将
用于确定凝胶滞留分析中的核因素,以及各种
标准将被应用于描述核蛋白-DNA复合体,
包括DNA序列特异性、DNA足迹和甲基化
干扰。DNA与结合蛋白接触点的致突变作用
因子及其对DNA结合和转录的影响
报告基因的激活,其中突变基序取代野生型
将对序列进行评估。已确认的核因素
参与调控的两种细胞因子的表达将被
利用寡核苷酸筛选cDNA表达文库进行克隆
由结合的DNA序列的串联重复组成,或通过直接
在COS细胞中的表达及凝胶滞留实验。另外,大自然和
Jun和Fos(或其相关蛋白)的作用将在
激活IL-3基因。第二,我们将从分子的角度进行研究
与T细胞相比,IL-3和GM-CSF的表达如何解偶联
巨噬细胞和成纤维细胞。染色质结构、启动子活性
和DNA核蛋白将在
使用前面列出的相同技术的不同细胞类型。分子
如果确定了新的核因子,也将进行克隆。在……里面
除了这些话题,人类表达IL-3的可能性
神经细胞将通过常规的RNA分析进行研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNARD MATHEY-PREVOT其他文献
BERNARD MATHEY-PREVOT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNARD MATHEY-PREVOT', 18)}}的其他基金
DERIVATION OF MODEL SYSTEMS FOR HEMATOPOIETIC GROWTH FACTOR RECEPTOR FUNCTION
造血生长因子受体功能模型系统的推导
- 批准号:
6105669 - 财政年份:1998
- 资助金额:
$ 19.36万 - 项目类别:
DERIVATION OF MODEL SYSTEMS FOR HEMATOPOIETIC GROWTH FACTOR RECEPTOR FUNCTION
造血生长因子受体功能模型系统的推导
- 批准号:
6239205 - 财政年份:1997
- 资助金额:
$ 19.36万 - 项目类别:
GENE REGULATION OF THE CYTOKINES IL-3 AND GM-CSF
细胞因子 IL-3 和 GM-CSF 的基因调控
- 批准号:
3242635 - 财政年份:1990
- 资助金额:
$ 19.36万 - 项目类别:
GENE REGULATION OF THE CYTOKINES IL-3 AND GM-CSF
细胞因子 IL-3 和 GM-CSF 的基因调控
- 批准号:
3242636 - 财政年份:1990
- 资助金额:
$ 19.36万 - 项目类别:
GENE REGULATION OF THE CYTOKINES IL3 AND GM CSF
细胞因子 IL3 和 GM CSF 的基因调控
- 批准号:
2141906 - 财政年份:1990
- 资助金额:
$ 19.36万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 19.36万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 19.36万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 19.36万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 19.36万 - 项目类别:
Discovery Grants Program - Individual